Gilead Sciences, Inc. $GILD Stock Sold by Hennessy Advisors Inc.
Alpha Vantage · MarketBeat · · AI-summarised by FinFlash
Hennessy Advisors Inc. reduced its stake in Gilead Sciences (NASDAQ:GILD) by 21.6% in the third quarter, selling 18,399 shares and retaining 66,800 shares valued at approximately $9.96 million. This reduction comes amidst strong third-quarter results for Gilead, which exceeded earnings and revenue expectations and raised its 2026 product-sales outlook due to high demand for HIV treatments.
Understand the context
Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.